Saturday 17 October 2026
Export MDCX’s income statement to Excel — free account
Medicus Pharma Ltd
MDCX Healthcare Drug Manufacturers General
In the quarter to June 2026, EPS grew 51.2% and free cash flow fell 27.7%, each against the same quarter a year earlier.
3.27
0.16
−4.66%
Follow MDCX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (7,441.07%) | (2,877.17%) | (2,981.87%) | (2,660.03%) |
+8 more TTM periods Free account |
|
| (290.34%) | (786.20%) | (602.13%) | (455.33%) | ||
ROIC |
(2,497.51%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(923.27%) | (3,870.91%) | 99,562.95% | 4,077.59% | |
Free Cash Flow per Share |
(0.53) | (0.94) | (1.32) | (1.04) | |
Free Cash Flow |
(29.32) | (27.81) | (22.78) | (19.36) | |
| Other line items | |||||
Cash ROIC |
(93.28%) | (356.78%) | (260.53%) | (246.39%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.52 | 0.54 | 0.48 | 0.54 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.53) | (0.94) | (1.32) | (1.04) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates